期刊文献+

亚胺培南/西司他丁钠治疗中重症肺炎的临床研究

Imipenem / cilastatin sodium in the treatment of severe pneumonia in clinical research
下载PDF
导出
摘要 目的观察亚胺培南/西司他丁钠在重症肺炎治疗方面的效果。方法在我院就诊的40例重症肺炎患者进行静脉滴注亚胺培南/西司他丁钠进行临床疗效及细菌学评价,以及病原菌敏感性分析。结果亚胺培南,西司他丁钠明显改善临床症状以及白细胞水平,药物敏感试验证实其较其他药物对病原菌敏感性好。结论亚胺培南/西司他丁钠在治疗重症肺炎中效果肯定,值得进一步推广。 Objective To observe the imipenem / cilastatin sodium in the treatment of severe pneumonia in effect. Method in our hospital, 40 cases of severe pneumonia in patients with intravenous infusion of imipenem / cilastatin sodium clinical efficacy and bacteriological evaluation, and sensitivity analysis of pathogens. The results of imipenem / cilastatin sodium significantly improved symptoms and white blood cells, drug sensitivity tests confirmed that the sensitivity of the pathogen than the other drugs better. Conclusion imipenem / eilastatin sodium in the treatment is effective for severe pneumonia, worthy of further promotion.
作者 黎涛
出处 《中国中医药咨讯》 2011年第18期131-132,共2页
关键词 亚胺培南/西司他丁钠 重症肺炎 imipenem / cilastatin sodium severe pneumonia
  • 相关文献

参考文献4

二级参考文献18

  • 1刘双,张京岚,马临安,肖遥,宗华,李勇,白树功.亚胺培南/西司他丁钠对重症感染的疗效观察[J].中华医院感染学杂志,2004,14(6):674-676. 被引量:6
  • 2王睿,陈迁,陈孟莉,吴坚,祝勇梅,刘桂兰.泰宁等7种抗菌药物对临床常见致病菌抗菌活性的比较[J].中国抗生素杂志,1994,19(5):356-362. 被引量:13
  • 3李军梅,刘刚,杨和平,何菊英,李学军,刘松青,刘平,胡建林.3种碳青霉烯抗生素体外抗菌活性及对肺部感染的疗效观察[J].第三军医大学学报,2005,27(13):1391-1393. 被引量:4
  • 4蒋丽娟,王涤非,王莉.美罗培南与亚胺培南-西司他丁钠治疗老年重度医院获得性肺炎的临床疗效[J].中国临床药学杂志,2005,14(4):237-240. 被引量:15
  • 5陈民伦,王清涛,许淑珍,等.1996年北京5家医院继续监测药性的结果[J].临床微生物学杂志,1997,3(1):1.
  • 6Norrby SR,Gildon KM. Safety profile of meropenem: a review of nearly5000 patients treated with meropenem [J]. Scond J Infect Dis, 1999,31(4):3.
  • 7Watannabe A, Tokue Y,Takahashi H, et al. Comparative invitro activity of carbapenem antibiotics against respiratory pathogens isolated between1999 and 2000[J]. Infect Chemother,2001,7(5) :267.
  • 8Kato K, Iwai S, Kumasaka K, et al. Survey of antibiotic resistance in Pseudomonas aeruginosa by the Tokyo Johoku Association of Pseudomonas studies[J]. Infect Chemother,2001,7(2) :258.
  • 9Afzal-shah M, Woodford N, Livermore DM, Characterization of OXA-25,OXA-26, OXA-27, molecular class D β-lactamases associated with carbapenem risistance in clinical isolates of Acinetobacter baumannii [ J ].Antimicrob Agents Chemother,2001,45(3) :582.
  • 10Watanabe A, Tokue Y, Takahashi H, et al. Comparative in-vitro activity of carbapenem antibiotics against respiratory pathogens isolated between 1999 and 2000[J]. J Infect Chemother, 2001, 7(4): 267- 271.

共引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部